Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bispecific antibody drug against COVID-19 jointly developed by Shanghai ZJ Bio-Tech and Sanyou Biopharmaceuticals appearing at China International Import Expo (CIIE) 2021-11-22 21:00
TenNor Reports Positive Results of TNP-2092 Capsule for the Treatment of Liver Cirrhosis Hyperammonemia 2021-11-22 21:00
Innovent Releases the ORIENT-31 Phase 3 Study First Interim Analysis Results of Sintilimab plus BYVASDA (bevacizumab biosimilar injection) and Chemotherapy in Patients with EGFR-mutated Nonsquamous Non-small Cell Lung Cancer who Progressed After EGFR-TKI Therapy at ESMO Virtual Plenary 2021 2021-11-22 08:16
Innovent Announces Inclusion of the Company's Stock (01801.HK) in the Hang Seng China Enterprises Index 2021-11-22 08:00
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China 2021-11-21 17:09
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China 2021-11-21 17:02
Successful 2020 Tang Prize Award Ceremony Highlights Laureates' Achievements and Influence 2021-11-20 15:00
Brii Biosciences Joins Hang Seng Composite Index 2021-11-19 19:06
Gracell Biotechnologies Granted FDA Orphan Drug Designation for FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy Candidate GC012F for the Treatment of Multiple Myeloma 2021-11-19 19:00
YHLO Revealed Its New Development of CLIA Technology at MEDICA 2021 2021-11-19 14:43
111, Inc. Announces Third Quarter 2021 Unaudited Financial Results 2021-11-19 13:31
ASRA 2021 | Cali Biosciences Presents Phase IIa Clinical Data on CPL-01, a Long-Acting Ropivacaine 2021-11-19 13:14
EQT Infrastructure to acquire Icon Group, Australia's largest integrated cancer care provider 2021-11-19 10:21
Investment Confidence in Icon Group to Drive Next Phase of Global Growth With EQT Infrastructure Investment 2021-11-19 09:19
Antengene Announces IND Approval in China for a Phase I/II Study of Selinexor (ATG-010) in Patients with Non-Hodgkin Lymphoma 2021-11-19 08:30
Treadwell Therapeutics Announces The Closing of a $91 Million Series B Financing 2021-11-18 20:00
ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth 2021-11-18 15:45
China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China 2021-11-18 15:00
China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China 2021-11-18 15:00
First Subject Dosed in the U.S. Phase I Trial for ASC43F Only Half a Month after IND Approval by the U.S. FDA 2021-11-18 08:30
1 210 211 212 213 214 413